Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Mouse models of infection for Neisseria meningitidis B,2b and Haemophilus influenzae type b diseases.

Brodeur BR, Tsang PS, Hamel J, Larose Y, Montplaisir S.

Can J Microbiol. 1986 Jan;32(1):33-7.

PMID:
3084050
2.

Lethal Haemophilus influenzae type b infection in mice.

Marks MI, Ziegler EJ, Douglas H, Corbeil LB.

Infection. 1982 Sep-Oct;10(5):261-6.

PMID:
6983499
3.

Intraperitoneal inoculation of Haemophilus influenzae local isolates in BALB/c mice model in the presence and absence of virulence enhancement agents.

Mojgani N, Maldjae V, Rahbar M, Mirafzali SM, Khoshnood S, Hatami A.

Indian J Med Microbiol. 2013 Apr-Jun;31(2):148-53. doi: 10.4103/0255-0857.115236.

5.

Iron as a replacement for mucin in the establishment of meningococcal infection in mice.

Calver GA, Kenny CP, Lavergne G.

Can J Microbiol. 1976 Jun;22(6):832-8.

PMID:
819118
6.
7.

Intranasal infection of infant mice with Neisseria meningitidis.

Mackinnon FG, Gorringe AR, Funnell SG, Robinson A.

Microb Pathog. 1992 Jun;12(6):415-20.

PMID:
1522796
8.

Virulence Enhancement Agents for Haemophilus influenzae type B infection in mice.

Sifontes Rodríguez S, Infante Bourzac JF, Marrero Chang O, Fariñas Medina M, Muñoz Carnago E, López Hernández Y.

Lab Anim Sci. 1999 Feb;49(1):95-8. Review. No abstract available.

PMID:
10090102
9.

Comparative virulence of Haemophilus influenzae with a type b or type d capsule.

Roberts M, Stull TL, Smith AL.

Infect Immun. 1981 May;32(2):518-24.

10.

Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Sutton A, Schneerson R, Kendall-Morris S, Robbins JB.

Infect Immun. 1982 Jan;35(1):95-104.

11.

Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?

Adderson EE, Byington CL, Spencer L, Kimball A, Hindiyeh M, Carroll K, Mottice S, Korgenski EK, Christenson JC, Pavia AT.

Pediatrics. 2001 Jul;108(1):E18.

PMID:
11433097
12.

Apparent meningococcemia: clinical features of disease due to Haemophilus influenzae and Neisseria meningitidis.

Jacobs RF, Hsi S, Wilson CB, Benjamin D, Smith AL, Morrow R.

Pediatrics. 1983 Oct;72(4):469-72.

PMID:
6412207
13.

[Brazilian purpuric fever, virulence in an animal model of Haemophilus aegyptius (H. influenzae biogroup aegyptius). Grupo de Estudo da Febre Purpúrica Brasileira].

Brandileone MC, Zanella RC, Tondella ML, Gheesling L, Vieira VS, Carlone GM.

Rev Inst Med Trop Sao Paulo. 1993 May-Jun;35(3):259-69. Portuguese.

PMID:
8278756
15.

Association of meningococcal serotypes with the course of disease: serotypes 2a and 2b in the Netherlands, 1959-1981.

Spanjaard L, Bol P, de Marie S, Zanen HC.

J Infect Dis. 1987 Feb;155(2):277-82.

PMID:
3100659
16.

Conserved virulence of C to B capsule switched Neisseria meningitidis clinical isolates belonging to ET-37/ST-11 clonal complex.

Lancellotti M, Guiyoule A, Ruckly C, Hong E, Alonso JM, Taha MK.

Microbes Infect. 2006 Jan;8(1):191-6. Epub 2005 Aug 15.

PMID:
16182586
17.

Diagnosis of bacteremia in children by quantitative direct plating and a radiometric procedure.

La Scolea LJ Jr, Dryja D, Sullivan TD, Mosovich L, Ellerstein N, Neter E.

J Clin Microbiol. 1981 Mar;13(3):478-82.

18.

Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.

Moxon ER, Hood D, Richards J.

Adv Exp Med Biol. 1998;435:237-43. Review. No abstract available.

PMID:
9498081
19.

Occult bacteremia with nontypeable Haemophilus influenzae.

Rubin LG, Staiman K, Kamani N.

J Clin Microbiol. 1987 Jul;25(7):1314-5.

20.
Items per page

Supplemental Content

Write to the Help Desk